BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2375060)

  • 1. [The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin A and Vibrio cholerae neuraminidase].
    Bratus' GG; Naumenko OI; Nastenko EP; Novichenko NL
    Tsitologiia; 1990; 32(1):67-73. PubMed ID: 2375060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modulating effect of immunotherapy with modified tumor cells in transplantable lymphoma].
    Bratus' GG; Darchuk GF; Komissarenko VG; Nastenko EP
    Eksp Onkol; 1987; 9(2):36-40. PubMed ID: 3582237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Vibrio cholerae neuraminidase on the mitogen response of T lymphocytes. I. Enhancement of macrophage T-lymphocyte cooperation in concanavalin-A-induced lymphocyte activation.
    Knop J
    Immunobiology; 1980 Dec; 157(4-5):474-85. PubMed ID: 6969689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Vibrio cholerae neuraminidase on the generation of cell-mediated cytotoxicity in vitro.
    Ferguson R; Anderson SM; Schmidtke JR; Simmons RL
    J Immunol; 1976 Dec; 117(6):2150-7. PubMed ID: 136474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Vibrio cholerae neuraminidase on the phagocytosis of E. coli by macrophages in vivo and in vitro.
    Knop J; Ax W; Sedlacek HH; Seiler FR
    Immunology; 1978 Mar; 34(3):555-63. PubMed ID: 346477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the enzyme neuraminidase for immunotherapeutic treatment of chemically induced carcinogenesis].
    Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Troitskaia NA; Gudkova GB
    Biull Eksp Biol Med; 1977 Dec; 84(12):714-7. PubMed ID: 413595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 9. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
    Pohajdak B; Wright JA; Greenberg AJ
    J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymically-modified human mammary carcinoma cells: modulators of macrophage functions.
    Hakim AA
    Cancer Biochem Biophys; 1979; 3(2):85-92. PubMed ID: 121921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 12. Thy-1+ epidermal cells proliferate in response to concanavalin A and interleukin 2.
    Nixon-Fulton JL; Bergstresser PR; Tigelaar RE
    J Immunol; 1986 Apr; 136(8):2776-86. PubMed ID: 2870120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of vibrio-cholerae neuraminidase (VCN) on the NK activity of peripheral blood lymphocytes in patients with cancer].
    Ohida J
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):114-21. PubMed ID: 3379327
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of Vibrio cholera neuraminidase on chemically induced carcinogenesis].
    Solov'ev VD; Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Gudkova RB
    Vestn Akad Med Nauk SSSR; 1974; (8):63-6. PubMed ID: 4471645
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
    Simmons RL; Rios A
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of in vivo neuraminidase on the regulation of erythropoiesis. II: Modulation of erythroid colony formation by thymic regulatory cells.
    La Russa VF; Sensenbrenner LL; Sharkis SJ
    Exp Hematol; 1989 Feb; 17(2):106-9. PubMed ID: 2563245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.